Dragonfly’s Qureshi Calls for End to Zcash Dev Fund After 2028
Lynx1 Capital Management LP, a 10% owner and director of Korro Bio, Inc. (), acquired common stock totaling $78,809 through two separate transactions in early August 2026. The purchases were made at weighted average prices ranging from $11.3998 to $13.1869 per
